HKSTP InnoAcademy — Technology Leaders of Tomorrow programme

HKSTP InnoAcademy — Technology Leaders of Tomorrow programme

On October 7th, 2020, Hong Kong Science and Technology Parks Corporation (HKSTP) announced the establishment of “HKSTP InnoAcademy” and the launch of “Technology Leaders of Tomorrow” (TLT) programme. Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”) was one of the participating partner companies which aims to incubate the future leaders in the Biomedical Technology […]

Zhaoke Ophthalmology and Nevakar Entered Into A License Agreement for NVK-002 — Introducing The Eye Treatment For Slowing The Progression of Myopia in Children in Greater China, SEA and South Korea Markets

License Transfer from Solasia to Lee’s Pharm for the Sales Promotion of Sancuso® and episil® in three cities in China

Lee’s Pharmaceutical Holdings Ltd. (“Lee’s Pharm” or “the Company”; Hong Kong stock code: 0950.HK), a research-based biopharmaceutical company, is pleased to announce that a wholly owned subsidiary of its associated company, Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd (“ZKO”) has recently entered into an exclusive licensing agreement with Nevakar Inc. (“Nevakar”), a US-based privately held, late-stage, […]

Concludes Series B Fundraising of approximately US$145 million for Zhaoke Ophthalmology — Marks Big Step Towards Achieving Possible Spin-off and Separate Listing

Unicycive announces Exclusive License and Development Agreement with Lee’s Pharmaceutical Holdings Limited for Renazorb in China and certain other Asian markets

Lee’s Pharmaceutical Holdings Ltd. (“Lee’s Pharm” or “the Company”; Hong Kong stock code: 0950.HK), a research-based biopharmaceutical company, is pleased to announce that following the close of trading on 9 October 2020 its associated company, Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology”), entered into a Subscription Agreement with Investors to issue an aggregate of 317,210 Series B […]

HKBIO and Lee’s Pharm Mask Donation Campaign

HKBIO and Lee’s Pharm Mask Donation Campaign

In view of the COVID-19 widespread, Hong Kong Biotechnology Organization (HKBIO) and Lee’s Pharmaceutical Holdings Ltd. (“Lee’s Pharm” or “the Group”) held a charitable mask donation campaign at Yuen Long Catholic Secondary School on March 10th, 2020. 6,000 masks were distributed to residents of Tuen Mun, Yuen Long and Tin Shui Wai. A total of […]

Donation of ERT-PCR Technology for New Coronavirus Detection Press Conference

Donation of ERT-PCR Technology for New Coronavirus Detection Press Conference

On March 3, 2020, Hong Kong Biotechnology Organization held a press conference at Hong Kong Science Park, announcing the donation of ERT-PCR Technology for New Coronavirus Detection. As one of the supporting organizations, Lee’s Pharmaceutical Holdings Ltd. (“Lee’s Pharm” or “the Group”) participated by donating protective materials. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News […]

Lee’s Pharm Cardiovascular Products Meeting of the 30th GW-ICC

Lee’s Pharm Cardiovascular Products Meeting of the 30th GW-ICC

On October 11th, 2019, Lee’s Pharmaceutical Holdings Ltd. (“Lee’s Pharm” or “the Group”) successfully hosted “Leading the Future – Lee’s Pharm Cardiovascular Products Meeting”, a satellite meeting at the China National Convention Center during the 30th Great Wall International Congress of Cardiology (GWICC). ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media

Greater Pediatrics, Greater Kids, Greater China ——Ferplex of Lee’s Pharmaceutical Holdings Ltd. appeared in the 24th Congress of Chinese Pediatric Society

Greater Pediatrics, Greater Kids, Greater China ——Ferplex of Lee’s Pharmaceutical Holdings Ltd. appeared in the 24th Congress of Chinese Pediatric Society

The 24th Congress of Chinese Pediatric Society, hosted by Chinese Medical Association and Chinese Pediatric Society, Chinese Medical Association (CPS), organized by Guangdong Medical Association, was held in Zhuhai International Conference & Exhibition Center from October 23 to 26, 2019. Congress and academic exchange were carried out simultaneously in the main venue and the 36 […]

Pre-IND meeting to communicate the combination of recombinant fully human anti- PD-L1 monoclonal antibody injection (ZKAB001 for short) and vaccinia GM-CSF/TK inactivated virus (Pexa-Vec, oncolytic virus)

Unicycive announces Exclusive License and Development Agreement with Lee’s Pharmaceutical Holdings Limited for Renazorb in China and certain other Asian markets

September 4, 2019, a pre-IND meeting to communicate the combination of recombinant fully human anti- PD-L1 monoclonal antibody injection (ZKAB001 for short) and vaccinia GM-CSF/TK inactivated virus (Pexa-Vec, oncolytic virus) has been held at the Drug Evaluation Center (CDE) of NMPA. CDE representatives include Zhou Ming (Major reviewer), Song Yuanyuan, Xia Lin, Chen Dongmei, Zhang […]

en_USEnglish